Abstract
Biotransfomation has been increasingly utilized as a tool to generate pharmaceutical lead compounds from natural products in recent years. A wide variety of natural pruducts including aromatics, steroids, alkaloids, coumarins, flavonoids and terpenoids can be biotransformed by fungi, yeasts, bacteria, plant cells and enzymes derived from these sources. The biochemical reactions occurring in microorganisms and plant cells are typically regio- and stereo-selective, which is difficult to be achieved by chemical methods. In this review we describe important biotransformations used for the generation of lead compounds with pharmaceutical utilities and further structural diversification of complex natural products, especially those from traditional Chinese medicines. Such approach will ultimately benefit the advancement of biotransformation and potential therapeutics.
Keywords: Biotransformation, Natural product, Bioactive compound, Enzyme catalysis, Drug discovery, Terpenoids, Alkaloids, Steroids
Current Organic Chemistry
Title: Biotransformation of Bioactive Natural Products for Pharmaceutical Lead Compounds
Volume: 14 Issue: 14
Author(s): Ji-Hua Liu and Bo-Yang Yu
Affiliation:
Keywords: Biotransformation, Natural product, Bioactive compound, Enzyme catalysis, Drug discovery, Terpenoids, Alkaloids, Steroids
Abstract: Biotransfomation has been increasingly utilized as a tool to generate pharmaceutical lead compounds from natural products in recent years. A wide variety of natural pruducts including aromatics, steroids, alkaloids, coumarins, flavonoids and terpenoids can be biotransformed by fungi, yeasts, bacteria, plant cells and enzymes derived from these sources. The biochemical reactions occurring in microorganisms and plant cells are typically regio- and stereo-selective, which is difficult to be achieved by chemical methods. In this review we describe important biotransformations used for the generation of lead compounds with pharmaceutical utilities and further structural diversification of complex natural products, especially those from traditional Chinese medicines. Such approach will ultimately benefit the advancement of biotransformation and potential therapeutics.
Export Options
About this article
Cite this article as:
Liu Ji-Hua and Yu Bo-Yang, Biotransformation of Bioactive Natural Products for Pharmaceutical Lead Compounds, Current Organic Chemistry 2010; 14 (14) . https://dx.doi.org/10.2174/138527210791616786
DOI https://dx.doi.org/10.2174/138527210791616786 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Application of Carbon Nanotubes In Drug Delivery of Non-cancerous Diseases: A Review
Current Pharmaceutical Design Vitamin D and Infectious Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Telemonitoring in the Management of High Blood Pressure
Current Pharmaceutical Design Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Mass Spectrometry Data Analysis in the Proteomics Era
Current Bioinformatics Biochemical Markers for Brain Injury Monitoring in Children with or without Congenital Heart Diseases
CNS & Neurological Disorders - Drug Targets Impaired Renal Function and Biomarkers of Vascular Disease in Alzheimer’s Disease
Current Alzheimer Research Synthesis and Enzymological Characterization of Some 2-(Substitutedphenylamino) quinazolin-4(3H)-one Derivatives as Potent α-Glucosidase Inhibitors In Vitro
Letters in Drug Design & Discovery Pulmonary Neuroendocrine Cell System in Health and Disease
Current Respiratory Medicine Reviews Atrial Fibrillation in Acute St-Elevation Myocardial Infarction: Clinical and Prognostic Features
Current Cardiology Reviews Taurine, Bone Growth and Bone Development
Current Nutrition & Food Science Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and Infection
Cardiovascular & Hematological Disorders-Drug Targets Synthesis, Docking and Antidiabetic Activity of Some Newer Benzamide Derivatives as Potential Glucokinase Activators
Letters in Drug Design & Discovery Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD
Current Pharmaceutical Design Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Current Pharmaceutical Design Targeting Strategies in Therapeutic Applications of Toxoplasmosis: Recent Advances in Liposomal Vaccine Delivery Systems
Current Drug Targets Patent Foramen Ovale in Cerebral Infarction
Current Cardiology Reviews Relationship between Diabetes Mellitus and Coronary Heart Disease
Current Diabetes Reviews Apoptosis in Anthracycline Cardiomyopathy
Current Pediatric Reviews The Road to Device Miniaturization in Echocardiography
Recent Patents on Medical Imaging